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The superinvasive phenotype exhibited by paclitaxel-selected variants of an in vitro invasive clonal population of the human cancer cell line,
MDA-MB-435S were examined using DIGE (Fluorescence 2-D Difference Gel Electrophoresis) and mass spectrometry. Isolation of membrane
proteins from the MDA-MB-435S-F/Taxol-10p4p and parental populations was performed by temperature-dependent phase partitioning using the
detergent Triton X-114. Subsequent DIGE-generated data analysed using Decyder software showed many differentially-expressed proteins in the
membrane fraction. 16 proteins showing statistically significant upregulation in the superinvasive cells were identified by MALDI-ToF. Proteins
upregulated in the superinvasive population include Galectin-3, Cofilin, ATP synthase beta subunit, voltage-dependent anion channel 1, voltage
dependent anion channel 2, ER-60 protein, MHC class II antigen DR52, Beta actin, TOMM40 protein, Enolase 1, Prohibitin, Guanine nucleotide-
binding protein, Annexin II, Heat shock 70 kDa protein, Stomatin-like protein 2 and Chaperonin. Many of these proteins are associated with
inhibition of apoptosis, the progression of cancer, tumourigenicity, metastasis, actin remodelling at the leading edge of cells, polarized cell growth,
endocytosis, phagocytosis, cellular activation, cytokinesis, and pathogen intracellular motility. These results suggest a correlation between the
increased abundance of these proteins with the superinvasive phenotype of the paclitaxel-selected MDA-MB-435S-F/Taxol-10p4p population.
© 2006 Elsevier B.V. All rights reserved.Keywords: Cofilin; DIGE; Galectin-3; Membrane protein; Superinvasive1. Introduction
The acquisition by cancer cells in the body of the metastatic
phenotype (whereby cells invade into neighbouring tissues and
across the blood or lymph vessel walls, travel in the blood or
lymph to distant sites where they lodge, invade and proliferate)
represents one of the most dangerous aspects of tumour
progression [1]. No good in vitro models for metastasis exist,
but recent research in our laboratory has identified an in vitro
phenotype, which has been termed superinvasiveness [2] which
appears to correlate with at least some aspects of the metastatic
phenotype both in vivo and in vitro [3]. The molecular basis for
the transition to the superinvasive phenotype is unknown. This
paper focuses on the identification of relevant changes at the
protein level in the membrane fraction of superinvasive cells as
compared to their non-superinvasive parental cell lines.⁎ Corresponding author. Tel.: +353 1 7005700/8291; fax: +353 1 7005484.
E-mail address: paul.dowling@dcu.ie (P. Dowling).
1570-9639/$ - see front matter © 2006 Elsevier B.V. All rights reserved.
doi:10.1016/j.bbapap.2006.09.014The cells discussed in this paper display a novel phenotype,
which we have termed ‘superinvasion’ in which cells not only
digest their way through extracellularmatrix andmigrate through
microtubules, as is standard in the Boyden Chamber assays, but
also detach from the underside of the chamber, survive in
suspension and re-attach to the surface of the microwell. This
phenotype is indicative of aggressive metastasis-like behaviour.
Anticancer drugs, as well as killing some cells, can cause
mutations in other cancer cells which survive. We have pre-
viously shown that drug exposure can result in the conversion of
cells from a non-invasive to an invasive phenotype [2], and our
identification of the superinvasive phenotype is a further obser-
vation of the multiple effects, not all desirable, which anticancer
drugs can exert on cells.
We focused on the membrane fraction because invasion is a
prerequisite for tumour metastasis and is associated with in-
creased cellular motility, the production of enzymes with proteo-
lytic activity and alterations in cell adhesion. Cell surface
proteins play important roles in cell signalling, adaptation to
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involved in the acquisition and maintenance of invasive and
metastatic properties of tumour cells. Identification of differen-
tially expressed proteins between parental and superinvasive
cells could therefore point to potential drug targets and diag-
nostic markers.
A CyDye™ DIGE fluorescent minimal labelling approach
was used to enrich and detect cell surface proteins in MDA-MB-
435S-F (parental clone) and MDA-MB-435S-F/Taxol-10p4p
(superinvasive variant) cell lines [4]. Fractionated cell mem-
brane proteins were separated using the fluorescent 2-D DIGE
technology and protein spot maps were further analysed with
DeCyder™ Differential Analysis Software.2. Materials and methods
2.1. Chemicals
Paclitaxel was obtained from Bristol-Myers Squibb (Dublin, Ireland). All
media and serum used in the maintenance of the cell lines were obtained from
Sigma Aldrich (Dublin, Ireland). Immobilized 24 cm linear pH gradient (IPG)
strips, pH 3–11, IPG Buffer and cyanine dyes Cy2, Cy3, and Cy5 were
purchased from Amersham (Amersham Biosciences, Inc.) Protein Assay and
membrane fractionation kits were purchased from Biorad (Biorad, Inc.). Unless
stated, all other chemicals were obtained from Sigma (Dublin, Ireland).
2.2. Cell lines
The human breast cancer cell line MDA-MB-435S was obtained from the
American type culture collection (ATCC) and was maintained in culture at 37 °C
using RPMI 1640 supplemented with 2 mM L-glutamine (Gibco) and 10% foetal
calf serum. MDA-MB-435S is a spindle-shaped strain which evolved from the
parental line MDA-MB-435 isolated by Cailleau et al., 1978, derived from the
pleural effusion of a 31-year-old female with metastatic, ductal adenocarcinoma
of the breast [5]. In 2002, results were published suggesting that MDA-MB-435
was of melanoma origin [6]. It was recently reported that the MDA-MB-435
cells used widely have identical origins to those that exhibit a melanoma-like
gene expression signature, but exhibit a small degree of genotypic and
phenotypic drift [7], but the possibility that some breast tumours may have gene
expression profiles similar to melanoma cannot be rules out. MDA-MB-435S-F
was obtained by clonal dilution from MDA-MB-435S in this laboratory. The
MDA-MB-435S-F paclitaxel-resistant variants were derived by pulse selection
of the parental cells with paclitaxel as previously described [2].
2.3. Invasion assays
Invasion assays were performed by a modification of the method previously
described [8]. Matrigel was diluted to 1 mg/ml in serum-free DMEMmedium. A
volume of 100 μl of 1 mg/ml Matrigel was placed into each insert (Falcon)
(8.0 μm pore size), which stood in wells of a 24-well plate (Costar). The inserts
and the plate were incubated overnight at 4 °C. The following day, cells were
harvested and suspended in RPMI 1640 containing 10% FCS at a concentration
of 1×106 cells/ml. The inserts were washed with serum-free RPMI 1640, and
then 100 μl of the cell suspension was added to each insert and 250 μl of RPMI
1640 containing 10% FCS was added to the insert well. Cells were incubated at
37 °C for 48 h. After this time period, the inner side of the insert was wiped with a
wet swab to remove the cells, while the outer side of the insert was gently rinsed
with PBS and stained with 0.25% crystal violet for 10 min, rinsed again and then
allowed to dry. The surface of the 24-well plate was rinsed gently twice with PBS
and stained with 0.25% crystal violet for 10min, rinsed again and then allowed to
dry. Cells were quantified by both counting with the aid of a light microscope and
eluting the stain with 200 μl 33% glacial acetic acid. Aliquots (100 μl) were
transferred to a 96-well plate and read in an ELISA reader at 570 nm with a
reference wavelength of 620 nm.2.4. Sample preparation and protein labelling
Cells at ∼80% confluence were washed twice in phosphate-buffered saline,
twice in sucrose buffer. Isolation of membrane proteins was performed on the
subsequent cell pellet employing Triton X 114. This is based on the separation of
membrane proteins by temperature-dependent phase partitioning using the
detergent Triton X-114 [9,10]. After a final centrifugation step, the sample
produces an upper aqueous phase and a lower detergent-rich phase. An insoluble
pellet is also formed and is a source of more complex membrane proteins.
Proteins extracted into the two phases are treated using the ReadyPrep 2-D
cleanup kit (Biorad) to remove agents in the extraction process that interfere
with IEF. The isolated membrane proteins were resuspended in buffer containing
(4% (w/v) CHAPS, 7 M urea, 2 M Thiourea, 10 mM Tris–HCl, 5 mM
Magnesium Acetate pH 8.5). Insoluble material was removed by centrifugation
at 14,000 rpm for 20 min at 10 °C. Protein concentration was determined using
the BSA protein assay kit (Biorad).
Cell lysates were labelled with N-hydroxy succinimidyl ester-derivatives of
the cyanine dyes Cy2, Cy3, and Cy5 following the protocol described
previously. Typically, 50 μg of lysate was minimally labelled with 200 pmol
of either Cy3 or Cy5 for comparison on the same 2D gel. Labelling reactions
were performed on ice in the dark for 30 min and then quenched with a 50-fold
molar excess of free lysine to dye for 10 min on ice. A pool of all samples was
also prepared and labelled with Cy2 to be used as a standard on all gels to aid
image matching and cross-gel statistical analysis. The Cy3 and Cy5 labelling
reactions (50 μg of each) from each lysate were mixed and run on the same gels
with an equal amount (50 μg) of Cy2-labelled standard [4]. Replicates of 3
different biological samples were analysed in this experiment.
2.5. Protein separation by 2D gel electrophoresis and gel imaging
Immobilized 24 cm linear pH gradient (IPG) strips, pH 3–11, were
rehydrated in rehydration buffer (7 M urea, 2 M Thiourea, 4% CHAPS, 0.5%
IPG Buffer, 50 mMDTT) overnight, according to the manufacturer's guidelines.
Isoelectric focusing was performed using an IPGphor apparatus (Amersham
Biosciences, Inc.) for a total of 40 kV/h at 20 °C, 50 mA. Strips were
equilibrated for 20 min in 50 mM Tris–HCl, pH 8.8, 6 M urea, 30% (v/v)
glycerol, 1% (w/v) SDS containing 65 mMDTTand then for 20 min in the same
buffer containing 240 mM iodoacetamide. Equilibrated IPG strips were
transferred onto 18×20 cm 12.5% uniform polyacrylamide gels poured between
low fluorescence glass plates. Strips were overlaid with 0.5% (w/v) low melting
point agarose in running buffer containing bromphenol blue. Gels were run
using the Ettan Dalt 6 apparatus (Amersham Biosciences, Inc.) at 2.5 W/gel for
30 min then 100 W in total at 10 °C until the dye front had run off the bottom of
the gels. All the images were collected on a Typhoon 9400 Variable Mode
Imager (Amersham Biosciences, Inc.). Statistics and quantitation of protein
expression were carried out in Decyder software (Amersham Biosciences, Inc.).
2.6. Spot digestion and MALDI-ToF analysis
Excision of protein spots, trypsin digestion, and protein identification by
mass spectrometric analysis using an Ettan MALDI-ToF Pro instrument from
Amersham Biosciences was performed according to an established methodol-
ogy. Preparative gels containing 300 μg of protein were fixed in 30% (v/v)
methanol, 7.5% (v/v) acetic acid overnight and washed in water, and total
protein was detected by post-staining with SyproRuby dye (Molecular Probes)
for 3 h at room temperature or Colloidal Coomassie (Sigma) for 2 h at room
temperature. Excess dye was removed by appropriate destaining/washing
methods. SyproRuby stained gels were imaged using a Typhoon 9400 Variable
Mode Imager (Amersham Biosciences, Inc.) at the appropriate excitation and
emission wavelengths for the stain. The subsequent gel image was imported into
the BVA module of DeCyder software and was matched to images generated
from DIGE analysis. Spots of interest were selected and confirmed using this
software for subsequent picking using an Ettan Spot Picker. Gel plugs were
placed into a presilconized 1.5 ml plastic tube for destaining, desalting and
washing steps. The remaining liquid above the gel plugs was removed and
sufficient acetonitrile was added in order to cover the gel plugs. Following
shrinkage of the gel plugs, acetonitrile was removed and the protein-containing
gel pieces were rehydrated for 5 min with a minimal volume of 100 mM
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15 min of incubation the solution was removed from the gel plugs and the
samples then dried down for 30 min using a vacuum centrifuge. Individual gel
pieces were then rehydrated in digestion buffer (12.5 ng trypsin per μl of 10%
Acetronitrile 40 mM Ammonium Bicarbonate) to cover the gel pieces. More
digestion buffer was added if all the initial volume had been absorbed by the gel
pieces. Exhaustive digestion was carried out overnight at 37 °C. After digestion,
the samples were centrifuged at 12,000×g for 10 min using a bench top
centrifuge. The supernatant was carefully removed from each sample and placed
into clean and silconized plastic tubes. Samples were stored at −70 °C until
analysed by MS. For spectrometric analysis, mixtures of tryptic peptides from
individual samples were desalted using Millipore C-18 Zip-Tips (Millipore) and
eluted onto the sample plate with the matrix solution [5 mg/ml a-cyano-4-
hydroxycinnamic acid in 50% acetonitrile/0.1% trifluoroacetic acid (v/v)]. Mass
spectra were recorded using the MALDI ToF instrument operating in the
positive reflector mode at the following parameters: accelerating voltage 20 kV;
and pulsed extraction: on (focus mass 2500). Internal and external calibration
was performed using trypsin autolysis peaks at m/z 842.50, m/z 2211.104 and
Pep4 mix respectively. The mass spectra were analysed using MALDI
evaluation software (Amersham Biosciences), and protein identification was
achieved with the PMF Pro-Found search engine for peptide mass fingerprints.
2.7. Statistical analysis
Two-sided, Student's t-tests were used to analyze differences in protein
levels between the parental line MDA-MB-435S-F and MDA-MB-435S-F/
Taxol-10p4p membrane protein cell lysates. A p-value of less than 0.05 was
considered statistically significant.Fig. 2. Images showing the morphology of (A) MDA-MB-435S-F and (B)
MDA-MB-435S-F/Taxol-10p4pSI cells.3. Results
3.1. Invasion assays
Fig. 1 describes the invasive capabilities of MDA-MB-435S-F.
Fig. 1 shows that while MDA-MB-435S-F is highly invasive,
selection with paclitaxel results in a more aggressive invasive
phenotype characterised by a proportion of the invading cells
detaching from the bottom of the insert and reattaching to the
bottom of the 24-well plate (superinvasion), which was negligible
in MDA-MB-435S-F. In vitro invasiveness for the positive control
cell line RPMI-2650Ml and negative control cell line RPMI-2650
[11] gave expected results (results not shown) and the super-
invasive phenotype was not observed in the positive control, as
previously reported. There is no apparent difference inmorphology
between MDA-MB-435S-F and MDA-MB-435S-F/Taxol-10p4p
cells as shown in Fig. 2.Fig. 1. Bar graph displaying the relative levels of superinvasion between MDA-
MB-435S-F and MDA-MB-435S-F/Taxol10p4pSI phenotypes.3.2. DIGE analysis
Protein differences were analyzed using two-dimensional
polyacrylamide gel electrophoresis (2D-PAGE, or 2D DIGE) to
resolve proteins based on their isoelectric points and their
molecular weight to generate a protein expression map (PEM)
shown in Fig. 3. The PEMs of MDA-MB-435S-F and MDA-
MB-435S-F/Taxol-10p4p can be compared and differentially
expressed proteins of interest can be detected using an internal
Cy2 labelled standard and DeCyder software. The precision of
2D DIGE is greatly improved if an internal standard is used with
this biological technique as each sample can then be compared
internally to the same standard, to account for any gel-to-gel
variation.
Automatic spot detection using DeCyder software was
followed by filtering of spots in each gel image to remove
those that obviously originated from dust particles and gel
impurities. After filtering, all six gels contained approximately
1500 protein spots. Automatic gel image matching was
supplemented by manual addition of around 10 landmarks to
guide the matching algorithm in subsequent re-matching
attempts. Landmarks, which aid the matching process, were
added in difficult areas, primarily near the edges/poor focusing
and in areas with many spots. Proteins split into separate spots
by the spot detection algorithm were manually merged during
Fig. 3. 2D DIGE image of Cy 2, Cy 3 and Cy 5 labelled MDA-MB-435S-F and
MDA-MB-435S-F/Taxol10p4pSI membrane proteins. Protein differences were
analyzed using two-dimensional polyacrylamide gel electrophoresis (2D DIGE)
to resolve proteins based on their isoelectric point, in this case a range of 3–11
was employed and their molecular weight to generate a protein expression map
(PEM).
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to have statistically significant differential expression are listed
in Table 1. Proteins listed in the table were overexpressed in
the MDA-MB-435S-F/Taxol-10p4p phenotype compared with
MDA-MB-435S-F, appeared in all six gels and attained a t-test
score of less than 0.02. All proteins were digested and
identified at least twice from separate gels with MALDI-ToF.
An expectation value of zero denotes a perfect match; an
expectation value of 0.01 indicates a 1% chance that the
identification is random. All reported identifications have an
expectation value of 0.01 or better. Other membrane proteinsTable 1
List of overexpressed proteins
Number Name t-test Average ratio Theorot
1 ATP synthase beta subunit 0.00013 1.84 56.54
2 Voltage-dependent anion channel 1 0.00012 1.95 30.74
3 ER-60 protein 0.00045 1.69 57.16
4 MHC class II antigen DR52 0.0033 1.56 27.22
5 Galectin-3 0.017 1.71 26.19
6 Actin, beta 0.00059 1.85 40.83
7 TOMM40 protein 0.0014 1.75 38.22
8 ENO1 protein 5.80E-05 1.84 47.49
9 Prohibitin 0.0012 1.7 29.87
10 Voltage-dependent anion channel 2 0.00021 1.91 30.84
11 Guanine nucleotide-binding protein 0.0017 1.74 38.16
12 Annexin II isoform 2 6.70E-05 1.58 38.81
13 Cofilin (non-muscle) 0.0001 1.81 18.71
14 Heat shock 70 kDa 8.10E 05 1.77 53.61
15 Stomatin-like protein 2 0.00017 1.87 38.63
16 Chaperonin 0.00014 1.82 61.21
Table of proteins found to be upregulated in MDA-MB-435S F/Taxol10p4pSI vs. M
analysis, t-test score, average ratio, theoretical mw, theoretical pI, % coverage and mwere found to be up-regulated but they were expressed at such
low levels that these proteins were not identified.
3.3. 3D images, statistics and mass spectrometry
Examples for the evaluation by DeCyder of alterations in
spot intensities using the DIGE system are displayed in Fig. 4.
To show visually alterations in corresponding spot intensity
proportions, the selected spots for VDAC-1, Heat Shock 70 kDa
protein, Galectin-3 and Cofilin are displayed as three-dimen-
sional (3D) images. Fig. 4 also displays the associated graph
views of standardized log abundances of the selected spots
among analyzed gel replicates. VDAC-1 was 1.95-fold
increased with a t-test score of 0.00012. Heat Shock 70 kDa
protein was 1.77-fold increased with a t-test score of 8.10E-05.
Galectin-3 was found to have an increased abundance of 1.71-
fold in the superinvasive phenotype with a t-test score of 0.017
whereas Cofilin had an increased abundance of 1.81-fold with a
t-test score of 0.0001.
A representative mass spectra for Heat Shock 70 kDa
protein as displayed in Fig. 5 were recorded using the
MALDI ToF instrument operating in the positive reflector
mode at the following parameters: accelerating voltage 20 kV;
and pulsed extraction: on (focus mass 2500). Internal and
external calibration was performed using trypsin autolysis
peaks at m/z 842.50, m/z 2211.104 and Pep4 mix respectively.
The mass spectra were analysed using MALDI evaluation
software (Amersham Biosciences), and protein identification
was achieved with the PMF Pro-Found search engine for
peptide mass fingerprints.
4. Discussion
A proteomics based approach was employed to look for
changes in membrane protein expression contributing to the
superinvasion seen in the MDA-MB-435S/Taxol-10p4p cellical MW Theorotical p.I %Coverage Molecular function
5.3 34.4 Transporter activity
8.8 55 Voltage-gated ion channel activity
5.9 33.1 Isomerase activity
6.8 34.6 MHC class II receptor activity
8.6 11.2 Transcription regulator activity
5.8 32.8 Cytoskeletal protein
6.8 29.1 Transporter activity
7 27.9 Catalytic activity
5.6 27.9 Receptor signaling complex scaffold
activity
8.4 33.3 Voltage-gated ion channel activity
5.6 41.8 G protein
7.7 32.2 Calcium ion binding
8.5 32.5 Cytoskeletal associated protein
5.6 33.1 Heat shock protein
6.9 34.8 Unknown
5.7 23.4 Chaperone
DA-MB-435S-F. Listed are the protein identities obtained from MALDI-ToF
olecular function.
Fig. 4. 3-D images and Statistical analysis of voltage dependent anion channel 1, heat shock 70 kDa protein, cofilin-1 and galectin-3. Images and statistics were generated using the BVA module of DeCyder software.
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MDA-MB-435S-F compared to MDA-MB-435S-F/Taxol-
10p4p cell populations showed an increase in expression levels
of many proteins.
Invasion and metastasis are complex processes involving
many critical stages and Galectin-3 was found to be implicated
in many of these including angiogenesis, cell matrix interactions
and tumour embolism [12–14]. The superinvasive cells
analysed in this study, display reduced attachment to ECM
proteins coupled with increased motility [2]. Galectin-3 is
involved in numerous cell–matrix and cell–cell interactions that
could play a pivotal role in the invasive and metastatic potential
of many cancers. Galectin-3 is known to function on the cell
surface and in the extracellular environment [15], bind laminin,
Lamp I and II, IgE and Mac-2 binding protein [16–18].
Carcinoma cells with high expression of galectin-3 such as
MDA-MB-435 interact well and spread very rapidly on ECM
proteins compared to those with low or no expression of
galectin-3 such as BT-549 [19,20]. Downregulation of galectin-
3 in MDA-MB-435 by the antisense approach has been reported
to give rise to a subclone which spreads poorly, grows poorly in
soft agar and forms tiny tumours in nude mice compared to the
cells transfected with the empty vector [21].
Previous work on Galectin-3 in our laboratory showed that
galectin-3 cDNA transfection into the human non-small cell
lung carcinoma cell line, DLKP, resulted in enhanced adhesion
to extracellular matrix components, cell motility and in vitro
invasiveness. Furthermore, studies of RPMI-2650 variants
suggest that galectin-3 expression correlates with nasalFig. 5. Representative MALDI-ToF generated spectrum for heat shock 70 kDa protei
for peptide mass fingerprints.carcinoma cell invasiveness [22]. Using the monoclonal
antibody M3/38 that was raised against glycoprotein extracts,
increased expression of Galectin-3 was observed in cancers
from thyroid [23], central nervous system [24], head and neck
squamous cell carcinoma [25], pancreas [26], bladder [27],
stomach [28] and renal carcinoma [29].
High serum galectin-3 levels have been reported in advanced
melanoma, with results suggesting that at least part of serum
Gal-3 might be produced by metastatic melanoma tissue [30].
Galectin-3 and CD1a-positive dendritic cells are involved in the
development of an invasive phenotype in vulvar squamous
lesions and may provide novel additions for the diagnosis of
invasion [31]. Galectin-3 enhances the metastatic potential of
human breast carcinoma BT549 cells by increasing resistance to
reactive nitrogen and oxygen species, such as NO and ONOO-,
most likely through the bcl-2-like antiapoptotic function of
galectin-3 [32]. The extracellular location of Galectin-3 on the
cell surface and in the extracellular milieu indicates its
participation in cell–cell and cell–matrix adhesion and interac-
tions. These observations suggest potential for galectin-3 as a
diagnostic/prognostic marker for specific cancer types and
cancer stages.
Cofilin is an actin-modulating protein and our results point to
an association with the superinvasive phenotype displayed by
the MDA-MB-435S-F/Taxol-10p4p. Cofilin and beta actin
were found to be overexpressed in the isolated membrane
fraction from MDA-MB-435S-F/Taxol-10p4p cells.
Cell migration is a critical step in tumour invasion where
reorganization of the actin cytoskeleton is the primaryn. Protein identifications were achieved using the PMF Pro-Found search engine
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migration [33]. Cofilin has an important function as a critical
regulator of actin dynamics and protrusive activity in cells [34],
in particular the formation of invadopodia, which are membrane
protrusions with a matrix degradation activity formed by
invasive cancer cells [35]. However, molecular mechanisms
that govern assembly and dynamics of invadopodia and the
involvement of cofilin are still not well understood. An early step
in cancer cell migration and invasion is the extension of cell
protrusions in the direction of cell movement [1]. Cofilin
nucleates actin polymerization by severing actin filaments to
generate free barbed ends [36] and also increases the rate of actin
depolymerization, thus maintaining a pool of actin monomer
[37]. Cofilin is one of the essential components for in vitro
reconstitution of Listeria monocytogenes motility that is driven
by actin polymerization [38], and it has recently been reported
that cofilin stimulates lamellipod protrusion and cell migration
[39–41]. Yamaguchi et al. proposed a model for invadopodium
formation where cofilin may be required for optimizing Arp2/3
complex-mediated dendritic nucleation to cause elongation of
the invadopodia and its stabilization [34]. From our data the
significant increase in the abundance of cofilin may have an
important role in mechanisms associated with superinvasion.
Heat shock proteins (Hsps) are synthesized by cells in
response to various stress conditions, including carcinogenesis,
with Hsps found to be overexpressed in a wide collection of
human cancers and are implicated in tumour cell proliferation,
differentiation, invasion and metastasis [42–44]. Increased
Hsp70 expression may also predict the response to some cancer
treatments, for example in resistance to chemotherapy in breast
cancer [45,46]. Our finding show that Hsp70 is overexpressed
in MDA-MB-435S-F/Taxol10p4pSI cells compared to MDA-
MB-435S-F cells and could be involved in the superinvasive
phenotype and/or in the paclitaxel-resistance phenotype.
Recently, differences in the expression of cell surface proteins
between a normal prostate epithelial cell line (1542-NP2TX)
and a prostate cancer cell line (1542-CP3TX) derived from the
same patient were investigated, and results included the
differential expression of VDAC-1 and VDAC-2 [47].
VDAC-1 and VDAC-2 were found to be 1.95-fold and 1.91-
fold increased respectively in this study.
Other proteins found to be overexpressed were Annexin II,
ENO1, SLP-2 and ATP synthase. Annexin II is a calcium- and
phospholipid-binding protein and a substrate for protein-
tyrosine kinases. Overexpression of Annexin II, which has
been reported in various carcinomas, is thought to be associated
with cell proliferation, differentiation, cell–cell adhesion and
recently it was found that annexin II might be an important
molecule in head and neck cancer invasion and metastasis.
Annexin II heterotetramer (AIIt) has been shown to play an
important role in degradation of extracellular matrix proteins, an
important step for tumour cell local invasion, angiogenesis, and
metastasis [48–50].
ENO1 is involved in the glycolytic pathway and was found
to be significantly overexpressed in the HER-2/neu-positive
breast tumours. HER-2/neu is overexpressed in up to 30% of
breast cancers and is associated with poor prognosis and anincreased likelihood of metastasis especially in node-positive
tumours. Takashima et al. showed that expression of alpha
enolase also correlated positively with tumour size and venous
invasion in hepatitis C virus-related hepatocellular carcinoma
(HCV-related HCC). These results suggest that alpha enolase is
a candidate biomarker for tumour progression [51,52]. SLP-2 is
a novel and unusual member of the stomatin gene superfamily.
Zhang et al. showed that SLP-2 was overexpressed in all tumour
types they tested compared with their normal counterparts.
Decreased cell growth, cell adhesion, and tumourigenesis in the
antisense transfectants revealed that SLP-2 may be important in
tumourigenesis [53–56].
ATP synthase occurs on the extracellular surface of a
variety of cancer cells and Choi et al. showed that treatment
with N-(4-methyl)phenyl-O-(4-methoxy)phenyl-thionocarba-
mate (MMTC) suppressed the metastasis of SK-MEL-8 cells
and is associated with reduced levels of ATP synthase.
Angiostatin, an antitumourigenic and antiangiogenic agent
has been found to act through a mechanism implicating tumour
cell surface ATP synthase [57,58].
In summary, selection of MDA-MB-435S-F with paclitaxel
generated a superinvasive population of cells, namely MDA-
MB-435S-F/Taxol-10p4p that is associated with upregulation of
many proteins isolated from membrane fractions. All proteins
listed have been implicated in tumour cell proliferation,
differentiation, invasion and metastasis to a greater or lesser
extent. It is probable that no single protein is responsible for the
superinvasive phenotype investigated in this study and it is
likely, based on the data presented here, that numerous proteins
are involved.
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